16 research outputs found
Mechanically stimulated osteocytes promote the proliferation and migration of breast cancer cells via a potential CXCL1/2 mechanism
Bone represents the most common site for breast cancer metastasis. Bone is a highly dynamic organ that is constantly adapting to its biophysical environment, orchestrated largely by the resident osteocyte network. Osteocytes subjected to physiologically relevant biophysical conditions may therefore represent a source of key factors mediating breast cancer cell metastasis to bone. Therefore, we investigated the potential proliferative and migratory capacity of soluble factors released by mechanically stimulated osteocytes on breast cancer cell behaviour. Interestingly the secretome of mechanically stimulated osteocytes enhanced both the proliferation and migration of cancer cells when compared to the secretome of statically cultured osteocytes, demonstrating that mechanical stimuli is an important physiological stimulus that should be considered when identifying potential targets. Using a cytokine array, we further identified a group of mechanically activated cytokines in the osteocyte secretome, which potentially drive breast cancer metastasis. In particular, CXCL1 and CXCL2 cytokines are highly expressed, mechanically regulated, and are known to interact with one another. Lastly, we demonstrate that these specific factors enhance breast cancer cell migration independently and in a synergistic manner, identifying potential osteocyte derived factors mediating breast cancer metastasis to bone
Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells
Increasing our knowledge of the mechanisms regulating cell proliferation, migration and invasion are central to
understanding tumour progression and metastasis. The local tumour microenvironment contributes to the transformed
phenotype in cancer by providing specific environmental cues that alter the cells behaviour and promotes metastasis.
Fibroblasts have a strong association with cancer and in recent times there has been some emphasis in designing
novel therapeutic strategies that alter fibroblast behaviour in the tumour microenvironment. Fibroblasts produce
growth factors, chemokines and many of the proteins laid down in the ECM (extracellular matrix) that promote
angiogenesis, inflammation and tumour progression. In this study, we use a label-free RTCA (real-time cell analysis)
platform (xCELLigence) to investigate how media derived from human fibroblasts alters cancer cell behaviour. We used
a series of complimentary and novel experimental approaches to show HCT116 cells adhere, proliferate and migrate
significantly faster in the presence of media from human fibroblasts. As well as this, we used the xCELLigence CIMplates
system to show that HCT116 cells invade matrigel layers aggressively when migrating towards media derived
from human fibroblasts. These data strongly suggest that fibroblasts have the ability to increase the migratory and
invasive properties of HCT116 cells. This is the first study that provides real-time data on fibroblast-mediated migration
and invasion kinetics of colon cancer cells
Optimization of an in vitro bioassay to monitor growth and formation of myotubes in real time
The importance of growth and maintenance of skeletal muscle is vital for long term health and quality of life. Appropriate nutrition with specific bioactivities relevant to the functionalities of tissues such as skeletal muscle, can assist in maintaining and promoting adaptive responses to biological and environmental stresses which prevent muscle atrophy and promote hypertrophy. The aim of this investigation was to develop a novel in vitro cell-based electric impedance assay to study myoblast to myotube formation on the real time cell analysis (RTCA) platform (xCELLigence (TM), ACEA) and to validate the system by testing myotube responses to hypertrophic stimuli. C2C12 myoblasts were proliferated until 70% confluent in Dulbecco's Modified Eagles Medium (DMEM) (10% FBS) and subsequently differentiated to myotubes over 8 days in DMEM [2% horse serum (HS)]. Changes in cell behaviour and adhesion properties were monitored by measuring impedance via interdigitated microelectrodes in the base of E-16 cell culture dishes. To establish the suitability of this assay to monitor nutrient regulation of muscle hypertrophy, leucine, a known potent regulator of MPS was then supplemented to the fully formed myotubes in physiologically relevant conditions - 0.20 mM, 0.40 mM, 0.6 mM, 0.8 mM and above 1.0 mM, 1.5 mM, 2.0 mM and impedance subsequently monitored. Parallel experiments highlighting alterations in myotube thickness, muscle protein synthesis (MPS) (mammalian target of rapamycin; mTOR) and differentiation (myogenin) were conducted to support RTCA bioassay findings. This in vitro bioassay can be used to monitor skeletal muscle behaviour and identify nutrient compounds with bioactivities promoting skeletal muscle hypertrophy, reducing muscle atrophy and thus inform the development of novel nutrient formulations for the maintenance of skeletal muscle
RACK1 stabilises the activity of PP2A to regulate the transformed phenotype in mammary epithelial cells
Conflicting reports implicate the scaffolding protein RACK1 in the progression of breast cancer. RACK1 has been identified as a key regulator downstream of growth factor and adhesion signalling and as a direct binding partner of PP2A. Our objective was to further characterise the interaction between PP2A and RACK1 and to advance our understanding of this complex in breast cancer cells. We examined how the PP2A holoenzyme is assembled on the RACK1 scaffold in MCF-7 cells. We used immobilized peptide arrays representing the entire PP2A-catalytic subunit to identify candidate amino acids on the C subunit of PP2A that might be involved in binding of RACK1. We identified the RACK1 interaction sites on PP2A. Stable cell lines expressing PP2A with FR69/70AA, R214A and Y218F substitutions were generated and it was confirmed that the RACK1/PP2A interaction is essential to stabilise PP2A activity. We used Real-Time Cell Analysis and a series of assays to demonstrate that disruption of the RACK1/PP2A complex also reduces the adhesion, proliferation, migration and invasion of breast cancer cells and plays a role in maintenance of the cancer phenotype. This work has significantly advanced our understanding of the RACK1/PP2A complex and suggests a pro-carcinogenic role for the RACK1/PP2A interaction. This work suggests that approaches to target the RACK1/PP2A complex are a viable option to regulate PP2A activity and identifies a novel potential therapeutic target in the treatment of breast cancer. (C) 2016 Elsevier Inc All rights reserved
Enhanced cell viability in hyaluronic acid coated poly(lactic-co-glycolic acid) porous scaffolds within microfluidic channels
The concept of the present work is to produce porous optimised scaffolds of poly(lactic-co-glycolic acid) (PLGA) coated with hyaluronic acid (HA), to provide a suitable microenvironment for cellular proliferation. Freeze dried scaffolds were produced from PLGA with varying lactic acid and glycolic acid ratios along the polymer backbone, as follows: 50:50 ester terminated, 50:50 carboxylate end-group and 85:15 ester terminated. Subsequently, these scaffolds were immersed in crosslinked HA in order for the coating to enhance biological performance. Scaffolds were fully characterized with respect to surface morphology, physical and chemical properties. The biocompatibility of the scaffolds was firstly evaluated using standard L929 fibroblast cells in static culture and subsequently MCF-7 breast cancer cells were seeded on scaffolds which were incorporated within a microfluidic device. The results show that cells were attracted to and adhered to the scaffolds, with a higher affinity for HA coated scaffolds. In our system, cell viability was maintained up to 48 h
Regulation of muscle protein synthesis in an in vitro cell model using ex vivo human serum
Human serum embodies the integrated systemic response to any condition or perturbation,
which may regulate muscle protein synthesis (MPS). Conditioning of medium with human serum
represents a physiologically relevant method of regulating MPS in vitro. The primary purpose of
the study was the development of a model using ex vivo human serum to condition medium and
regulate MPS in in vitro skeletal muscle cells. Four young healthy men reported to the laboratory
after an overnight fast and were fed with 0.33 g (kg body mass)â1 whey protein. Blood samples
were taken before (Fasted) and 60 min postprandial (Fed). Fully differentiated C2C12 skeletal
muscle cells were nutrient and serum deprived for 1 h and subsequently treated with medium
conditioned with Fasted or Fed ex vivo human serum (20%) for 4 h. The MPS was measured
using the surface sensing of translation technique and activation of mTOR, P70S6K and 4EBP1
by Western blot. Fasted and fed ex vivo human serum increased MPS (P < 0.05). Although a
strong effect (Æ2 = 0.36) for increased MPS in Fed relative to Fasted was observed, this was
not statistically significant (P > 0.05). Activation of mTOR, P70S6K and 4EBP1 was significantly
increased after treatment with Fed compared with Fasted ex vivo human serum (P < 0.05).
Here, we developed and optimized the conditions for culture of C2C12 skeletal muscle cells,
measurement ofMPS and signalling inmedium conditioned by ex vivo human serum. Furthermore,
the functionality of the model was demonstrated by comparison of the response to medium
conditioned by Fasted and Fed ex vivo human serum
The human mesenteric lymph node microbiome differentiates between Crohnâs disease and ulcerative colitis
Background and Aims:
Mesenteric lymph nodes are sites in which translocated bacteria incite and
progress immunological responses. For this reason, understanding the microbiome of mesenteric
lymph nodes in inflammatory bowel disease is important. The bacterial profile of Crohnâs disease
mesenteric lymph nodes has been analysed using culture-independent methods in only one
previous study. This study aimed to investigate the mesenteric lymph node microbiota from both
Crohnâs disease and ulcerative colitis patients.
Methods: Mesenteric lymph nodes were collected from Crohnâs disease and ulcerative colitis
patients undergoing resection. Total DNA was extracted from mesenteric lymph nodes and
assessed for the presence of bacterial DNA [16S]. All work was completed in a sterile environment
using aseptic techniques. Samples positive for 16S DNA underwent next-generation sequencing,
and the identity of bacterial phyla and species were determined.
Results: Crohnâs disease mesenteric lymph nodes had a distinctly different microbial profile to
that observed in ulcerative colitis. The relative abundance of Firmicutes was greater in nodes from
ulcerative colitis patients, whereas Proteobacteria were more abundant in Crohnâs disease. Although
species diversity was reduced in the mesenteric lymph nodes of patients with Crohnâs disease,
these lymph nodes contained greater numbers of less dominant phyla, mainly Fusobacteria.
Conclusion: This study confirms that there are distinct differences between the Crohnâs disease
and ulcerative colitis mesenteric lymph node microbiomes. Such microbial differences could aid in
the diagnosis of Crohnâs disease or ulcerative colitis, particularly in cases of indeterminate colitis at
time of resection, or help explain their mechanisms of development and progression
The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-kB subunits
The transcription factor NF-kB is a master regulator of the innate immune response and plays a central role in inflammatory diseases by mediating the expression of pro-inflammatory cytokines.Ubiquitination-triggered proteasomal degradation of DNA-bound NF-kB strongly limits the expression of its target genes. Conversely, USP7 (deubiquitinase ubiquitin-specific peptidase7) opposes the activities of E3ligases,stabilizes DNAbound NF-kB, and thereby promotes NF-kBâmediated transcription. Using gene expression and synthetic peptide arrays on membrane support and overlay analyses, we found here that inhibiting USP7 increases NF-kB ubiquitination and degradation, prevents Toll-like receptorâinduced pro-inflammatory cytokine expression, and represents an effective strategy for controlling inflammation. However, the broad regulatory roles of USP7 in cell death pathways, chromatin, and DNA damage responses limit the use of catalytic inhibitors of USP7 as anti inflammatory agents. To this end,we identified nNF-kBâbinding site in USP7, ubiquitin-like domain 2, that selectively mediates interactions of USP7 with NF-kB subunits but is dispensable for interactions with other proteins. Moreover, we found that the amino acids 757LDEL760 in USP7 critically contribute to the interaction with the p65 subunit of NF-ĆB. Our findings support the notion that USP7 activity could be potentially targeted in a substrate-selective manner through the development of noncatalytic inhibitors of this deubiquitinase to abrogate NF-kB activity
Large-scale characterization of hospital wastewater system microbiomes and clinical isolates from infected patients: profiling of multi-drug-resistant microbial species
BackgroundHospital-acquired infections (HAIs) and infectious agents exhibiting antimicrobial resistance (AMR) are challenges globally. Environmental patient-facing wastewater apparatus including handwashing sinks, showers and toilets are increasingly identified as sources of infectious agents and AMR genes.AimTo provide large-scale metagenomics analysis of wastewater systems in a large teaching hospital in the Republic of Ireland experiencing multi-drug-resistant HAI outbreaks.MethodsWastewater pipe sections (N=20) were removed immediately prior to refurbishment of a medical ward where HAIs had been endemic. These comprised toilet U-bends, and sink and shower drains. Following DNA extraction, each pipe section underwent metagenomic analysis.FindingsDiverse taxonomic and resistome profiles were observed, with members of phyla Proteobacteria and Actinobacteria dominating (38.23 ± 5.68% and 15.78 ± 3.53%, respectively). Genomes of five clinical isolates were analysed. These AMR bacterial isolates were from patients >48 h post-admission to the ward. Genomic analysis determined that the isolates bore a high number of antimicrobial resistance genes (ARGs).ConclusionComparison of resistome profiles of isolates and wastewater metagenomes revealed high degrees of similarity, with many identical ARGs shared, suggesting probable acquisition post-admission. The highest numbers of ARGs observed were those encoding resistance to clinically significant and commonly used antibiotic classes. Average nucleotide identity analysis confirmed the presence of highly similar or identical genomes in clinical isolates and wastewater pipes. These unique large-scale analyses reinforce the need for regular cleaning and decontamination of patient-facing hospital wastewater pipes and effective infection control policies to prevent transmission of nosocomial infection and emergence of AMR within potential wastewater reservoirs.</p
Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival
Despite extensive efforts, cancer therapies directed at the Protein Kinase C (PKC) family of serine/threonine kinases have failed in clinical trials. These therapies have been directed at inhibiting PKC and have, in some cases, worsened disease outcome. Here we examine colon cancer patients and show not only that PKC Beta II is a tumour suppressor, but patients with low levels of this isozyme have significantly decreased disease free survival. Specifically, analysis of gene expression levels of all PKC genes in matched normal and cancer tissue samples from colon cancer patients revealed a striking down-regulation of the gene coding PKC Beta in the cancer tissue (n = 21). Tissue microarray analysis revealed a dramatic down-regulation of PKC Beta II protein levels in both the epithelial and stromal diseased tissue (n = 166). Of clinical significance, low levels of the protein in the normal tissue of patients is associated with a low (10%) 10 year survival compared with a much higher (60%) survival in patients with relatively high levels of the protein. Consistent with PKC Beta II levels protecting against colon cancer, overexpression of PKC Beta II in colon cancer cell lines reveals that PKC Beta II reverses transformation in cell based assays. Further to this, activation of PKC Beta II results in a dramatic downregulation of IGF-I-induced AKT, indicating a role for PKCs in regulating IGF-1 mediated cell survival. Thus, PKC Beta II is a tumour suppressor in colon cancer and low levels serve as a predictor for poor survival outcome